California Public Employees Retirement System Biogen Inc. Transaction History

California Public Employees Retirement System

$135 Billion
Q2 2024

A detailed history of California Public Employees Retirement System transactions in Biogen Inc. stock. As of the latest transaction made, California Public Employees Retirement System holds 396,065 shares of BIIB stock, worth $68.8 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

396,065

Previous 404,419 2.07%

Holding current value

$68.8 Million

Previous $87.2 Million 5.29%

% of portfolio

0.07%

Previous 0.06%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $1.59 Million - $1.98 Million	-8,354 Reduced 2.07%	396,065 $91.8 Million
Q1 2024 Apr 30, 2024	BUY	$212.02 - $267.71 $8.74 Million - $11 Million	41,210 Added 11.35%	404,419 $87.2 Million
Q4 2023 Feb 01, 2024	BUY	$222.59 - $267.94 $18.3 Million - $22 Million	82,046 Added 29.18%	363,209 $94 Million
Q3 2023 Nov 02, 2023	BUY	$253.3 - $285.89 $1.65 Million - $1.87 Million	6,532 Added 2.38%	281,163 $72.3 Million
Q2 2023 Aug 09, 2023	SELL	$275.25 - $318.06 $9.63 Million - $11.1 Million	-34,986 Reduced 11.3%	274,631 $78.2 Million
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $16 Million - $18.2 Million	-62,275 Reduced 16.75%	309,617 $86.1 Million
Q4 2022 Feb 08, 2023	SELL	$252.44 - $306.72 $3.56 Million - $4.33 Million	-14,101 Reduced 3.65%	371,892 $103 Million
Q3 2022 Nov 09, 2022	BUY	$194.69 - $268.46 $2.74 Million - $3.78 Million	14,096 Added 3.79%	385,993 $103 Million
Q2 2022 Aug 10, 2022	SELL	$187.54 - $223.02 $10.2 Million - $12.1 Million	-54,459 Reduced 12.77%	371,897 $75.8 Million
Q1 2022 May 04, 2022	SELL	$193.77 - $244.14 $4.73 Million - $5.95 Million	-24,385 Reduced 5.41%	426,356 $89.8 Million
Q4 2021 Feb 10, 2022	SELL	$223.92 - $287.77 $3.92 Million - $5.04 Million	-17,527 Reduced 3.74%	450,741 $108 Million
Q3 2021 Nov 10, 2021	SELL	$282.99 - $369.05 $1.48 Million - $1.93 Million	-5,238 Reduced 1.11%	468,268 $133 Million
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $26.1 Million - $41.8 Million	100,803 Added 27.05%	473,506 $164 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $3.65 Million - $4.27 Million	-15,019 Reduced 3.87%	372,703 $104 Million
Q4 2020 Feb 02, 2021	BUY	$236.26 - $355.63 $1.98 Million - $2.98 Million	8,375 Added 2.21%	387,722 $94.9 Million
Q3 2020 Nov 05, 2020	BUY	$264.77 - $305.71 $261,327 - $301,735	987 Added 0.26%	379,347 $108 Million
Q2 2020 Aug 12, 2020	SELL	$258.66 - $342.55 $6.19 Million - $8.2 Million	-23,929 Reduced 5.95%	378,360 $101 Million
Q1 2020 May 12, 2020	SELL	$268.85 - $341.04 $14 Million - $17.7 Million	-51,914 Reduced 11.43%	402,289 $127 Million
Q4 2019 Jan 27, 2020	SELL	$220.06 - $304.07 $9.09 Million - $12.6 Million	-41,328 Reduced 8.34%	454,203 $135 Million
Q3 2019 Oct 31, 2019	BUY	$217.44 - $243.88 $8.51 Million - $9.54 Million	39,137 Added 8.58%	495,531 $115 Million
Q2 2019 Aug 15, 2019	SELL	$219.29 - $241.72 $5.54 Million - $6.11 Million	-25,279 Reduced 5.25%	456,394 $107 Million
Q1 2019 May 03, 2019	BUY	$216.71 - $338.96 $378,158 - $591,485	1,745 Added 0.36%	481,673 $114 Million
Q4 2018 Feb 08, 2019	SELL	$278.5 - $352.75 $8.35 Million - $10.6 Million	-29,969 Reduced 5.88%	479,928 $144 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $11.4 Million - $14.9 Million	-38,778 Reduced 7.07%	509,897 $180 Million
Q2 2018 Aug 15, 2018	BUY	$257.52 - $306.91 $139,060 - $165,731	540 Added 0.1%	548,675 $159 Million
Q1 2018 May 11, 2018	BUY	$260.13 - $367.91 $4.14 Million - $5.85 Million	15,899 Added 2.99%	548,135 $150 Million
Q4 2017 Feb 06, 2018	BUY	$307.64 - $344.58 $8.83 Million - $9.9 Million	28,718 Added 5.7%	532,236 $170 Million
Q3 2017 Nov 15, 2017	BUY	$281.15 - $329.69 $142 Million - $166 Million	503,518	503,518 $158 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account

California Public Employees Retirement System Biogen Inc. Transaction History